A carregar...
Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy
Tumor lysis syndrome (TLS) is characterized by hyperuricaemia, hyperphosphatemia, hyperkalaemia, as well as hypocalcaemia due to the breakdown of tumor cells undergoing cancer therapy (chemo/radio). Therefore it is of interest to evaluate oxidative stress using selective biological markers [Malondia...
Na minha lista:
| Publicado no: | Bioinformation |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Biomedical Informatics
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261116/ https://ncbi.nlm.nih.gov/pubmed/25512688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630010703 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|